Ariz., Bristol-Myers Squibb Settle AWP Drug Case

Law360, New York (September 17, 2009, 1:37 PM EDT) -- The state of Arizona has asked a court to dismiss Bristol-Myers Squibb Co. from multidistrict litigation accusing a number of pharmaceutical companies of scheming to artificially boost average wholesale drug prices, following a settlement agreement between the two parties.

In a motion to dismiss filed Wednesday in the U.S. District Court for the District of Massachusetts, Arizona said Bristol-Myers and related entities Oncology Therapeutics Network Corp. and Apothecon Inc. had agreed to settle with the state and could be released from the litigation.

Under the settlement,...
To view the full article, register now.